Rechallenge with imatinib in GIST: Is more always RIGHT?

Damien Urban; Jeremy Lewin; Ian M. Collins; Jennifer Mooi; Michael Jefford

doi:10.1016/S1470-2045(13)70531-X

Rechallenge with imatinib in GIST: Is more always RIGHT?

Damien Urban^*, Jeremy Lewin, Ian M. Collins, Jennifer Mooi, Michael Jefford

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	e2
Journal	The Lancet Oncology
Volume	15
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(13)70531-X
State	Published - Jan 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1470-2045(13)70531-X

Cite this

@article{f5ae408587624fe891454af8ee949706,

title = "Rechallenge with imatinib in GIST: Is more always RIGHT?",

author = "Damien Urban and Jeremy Lewin and Collins, {Ian M.} and Jennifer Mooi and Michael Jefford",

year = "2014",

month = jan,

doi = "10.1016/S1470-2045(13)70531-X",

language = "אנגלית",

volume = "15",

pages = "e2",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "1",

}

TY - JOUR

T1 - Rechallenge with imatinib in GIST

T2 - Is more always RIGHT?

AU - Urban, Damien

AU - Lewin, Jeremy

AU - Collins, Ian M.

AU - Mooi, Jennifer

AU - Jefford, Michael

PY - 2014/1

Y1 - 2014/1

UR - http://www.scopus.com/inward/record.url?scp=84891370457&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(13)70531-X

DO - 10.1016/S1470-2045(13)70531-X

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 24384490

AN - SCOPUS:84891370457

SN - 1470-2045

VL - 15

SP - e2

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 1

ER -

Rechallenge with imatinib in GIST: Is more always RIGHT?

UN SDGs

Access to Document

Other files and links

Cite this